四川双马(000935.SZ)控股子公司湖北健翔获得出口欧盟证明文件

Core Viewpoint - Sichuan Shuangma (000935.SZ) announced that its subsidiary Hubei Jianxiang Biopharmaceutical Co., Ltd. has received the GMP compliance inspection notice and EU export certificate from the Hubei Provincial Drug Administration, indicating compliance with international drug production quality management standards [1] Group 1 - Hubei Jianxiang's A101 workshop production line for the raw material drug Liraglutide has passed the on-site inspection by the Hubei Provincial Drug Administration [1] - The compliance with China's GMP standards is equivalent to the requirements set by the EU, World Health Organization, and ICH Q7 guidelines [1]